Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
- 1 January 1998
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 184 (1) , 53-57
- https://doi.org/10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7
Abstract
Growth factors may play an important role in tumour growth and angiogenesis by their influence on tumour cell proliferation or their effect on neovascularization. The aim of the present study was to determine which of the growth factors, growth‐inhibiting factors, and their receptors investigated in a previous study are correlated with proliferation and angiogenesis in invasive breast cancer, with emphasis on the impact of possible autocrine and paracrine loops. Five growth factors and their receptors: platelet‐derived growth factor A chain (PDGF‐AA) and PDGF alpha receptor (PDGFαR), PDGF‐BB and PDGF beta receptor (PDGFβR), transforming growth factor alpha (TGFα) and its receptor epidermal growth factor receptor (EGFR), and vascular endothelial growth factor (VEGF) and its receptors (Flt‐1 and Flk‐1/KDR; two growth‐inhibiting factors: transforming growth factor beta‐1 (TGFβ1) and TGFβ2 and their receptor couple TGFβR‐I and TGFβR‐II; and basic fibroblast growth factor (bFGF) were stained in 45 cases of invasive breast cancer by standard immunohistochemistry on frozen sections. Staining in tumour cells, stromal cells, and endothelial cells was scored as negative or positive. Proliferation was determined by assessment of the mitotic activity index (MAI) and the degree of angiogenesis was measure by counting the number of microvessels (microvessel density: MVD) in the most vascularized area of the tumour. bFGF and EGFR showed positive correlations with the MAI, while TGFβ2 showed a negative correlation. Expression of bFGF, TGFα, TGFβ2, and EGFR correlated positively with the MVD. Co‐expression of the TGFα/EGFR growth factor/receptor combination showed a stronger correlation with the MAI and the MVD than EGFR or TGFα alone, and the TGFβ2/TGFβR‐I/TGFβR‐II combination showed a positive correlation with the MVD. In conclusion, the expression of several growth factors, growth factor receptors, and growth‐inhibiting factors showed correlations with the rate of proliferation and the degree of angiogenesis in invasive breast cancer. Some growth factor/receptor combinations showed stronger correlations with proliferation and angiogenesis than the growth factor or receptor alone, pointing to the importance of possible auto‐ and paracrine loops for stimulation of proliferation and angiogenesis by growth factors and their receptors. © 1998 John Wiley & Sons, Ltd.Keywords
This publication has 41 references indexed in Scilit:
- Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor β in breast cancerBritish Journal of Cancer, 1996
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Expression of transforming growth factor beta mRNA isoforms in human breast cancerBritish Journal of Cancer, 1994
- The prognostic significance of transforming growth factors in human breast cancerBritish Journal of Cancer, 1993
- Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancerBritish Journal of Cancer, 1992
- Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissuesBritish Journal of Cancer, 1992
- Prognostic factors in axillary lymph node-negative (pN−) breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1991
- The Transforming Growth Factor-βsPublished by Springer Nature ,1990
- Ki67 immunostaining in primary breast cancer: pathological and clinical associationsBritish Journal of Cancer, 1989
- The value of morphometry to classic prognosticators in breast cancerCancer, 1985